Home > Compound List > Product Information
Deferoxamine Mesylate_Molecular_structure_CAS_138-14-7)
Click picture or here to close

Deferoxamine Mesylate

Catalog No. D228980 Name Toronto Research Chemicals
CAS Number 138-14-7 Website http://www.trc-canada.com
M. F. C26H52N6O11S Telephone +1 (416) 665-9696
M. W. 656.78968 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Chembase ID: 134221

SYNONYMS

IUPAC name
N-(5-aminopentyl)-N-hydroxy-N'-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]butanediamide; methanesulfonic acid
IUPAC Traditional name
deferoxamine; methanesulfonic acid
Synonyms
NSC 644468
DFX mesylate
Desferal mesylate
Deferoxamine B mesylate
Deferoxamine methanesulfonate
Ba 33112
DFOM
N1-(5-aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide Methanesulfonate
N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid Methanesulfonate
Deferrioxamine B methanesulfonate
Desferrioxamine B mesylate
Desferrioxamine methanesulfonate

DATABASE IDS

CAS Number 138-14-7

PROPERTIES

Certificate of Analysis Download
MSDS Link Download

DETAILS

Description (English)
An iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients

REFERENCES

  • Inati, A. et al.: Am. J. Hematol., 85, 782 (2010)
  • Selim, M.: Translat. Stroke Res., 1, 35 (2010)
  • Cappellini, M.D. et al.: Hemoblobin, 33, 258 (2010)